サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：自己血輸血システムの世界市場-2023年～2030年
市場調査レポート
商品コード
1319141

自己血輸血システムの世界市場-2023年～2030年

Global Autotransfusion System Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
自己血輸血システムの世界市場-2023年～2030年
出版日: 2023年07月31日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の自己血輸血システム市場は、2022年に3億2,140万米ドルに達し、2023-2030年の予測期間中にCAGR 5.3%で成長し、2030年には4億8,260万米ドルに達すると予測されています。

自己血輸血とは、輸血のために、バンクに保管されている同種血液（分離ドナー血液）の代わりに自分の血液を受け取るプロセスです。自己血輸血の目的は、無菌状態の維持、採取した血液の凝固防止、血液の濾過、患者への投与であることに変わりはないです。

市場力学

血管手術の増加が自己血輸血システム市場を牽引

自己血輸血市場を牽引している主な要因は、血管手術件数の増加です。多くの人々が血管の病気に苦しんでおり、拒絶反応を避けるために自己血輸血治療が行われています。

例えば、Journal of Vascular Surgery誌によると、年間107件の手術が行われています。血管外科医の定義されたコホートの中で、11％が200以上の手術を行い、21％が50以下でした。平均すると、血管外科医による年間手術件数は107件でした。このように、血管手術数の増加が市場成長を増大させています。

技術進歩の高まりが世界の自己血輸血システム市場の成長を要求

自己血輸血における新技術の導入と発展が、自己血輸血システム市場の原動力となっています。例えば、2022年、NIHは、術中に採取された血液を収集・洗浄し、プロセスの最後に濃縮された血液製剤を得る目的であったとする研究を明らかにしました。

このデバイスには、中空糸による革新的な濾過技術が統合されており、赤血球の濃縮だけでなく、濃縮血液製剤内の血小板の濃縮や汚染物質の除去も可能になります。このように、技術開発が自己血輸血システム市場の原動力となっています。

手順を実行する熟練した専門家の不足が市場成長の妨げになる可能性

自己血輸血システムをより適切に実施する熟練した専門家の数が減少すると、市場の成長が低下します。様々な種類の手術が増加しているため、患者を治療するために十分な数の専門家が必要とされています。したがって、熟練した専門家の数が減少すると、市場の成長が低下する可能性があります。

COVID-19影響分析

COVID-19パンデミックの流行は、自己血輸血市場にマイナスの影響を与えています。多くの自己血輸血センターと診断センターが閉鎖され、多くの患者が影響を受け、輸血率が低下しました。自己血輸血治療が延期されたため、深刻な健康問題が発生し、その結果、治療を受けられない患者が大幅に増加しました。

ロシア・ウクライナ紛争影響分析

ロシア・ウクライナ紛争は、この地域の主要市場プレーヤーの数が少ないため、世界の自己血輸血システム市場に与える影響は中程度と推定されます。しかし、原材料の輸出入の影響は、予測期間中、世界の自己血輸血システム市場の成長にほとんど影響を与えないと予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 大量出血を伴う手術の増加
      • ドナー不足の増加
    • 抑制要因
      • 自己血輸血システムの高コスト
    • 機会
      • 製品開発における技術の進歩
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 ロシア・ウクライナ戦争影響分析

第8章 製品タイプ別

  • 術中自己血輸血システム
  • 術後自己血輸血システム
  • デュアルモード自己血輸血システム
  • 自己血輸血アクセサリー

第9章 技術別

  • 事前自己血輸血（PAD）
  • 急性正常血液希釈（ANH）
  • 周術期細胞サルベージ（PCS）

第10章 用途別

  • 整形外科
  • 神経学
  • 心臓学
  • その他

第11章 エンドユーザー別

  • 病院
  • 専門クリニック
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • Armstrong Medical.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Beijing ZKSK Technology
  • Medtronic
  • Haemonetics
  • LivaNova
  • BD
  • Zimmer
  • Terumo BCT
  • Atrium Medical Corporation
  • Fresenius Kabi

第15章 付録

目次
Product Code: MD6545

Market Overview

Global Autotransfusion System Market reached US$ 321.4 million in 2022 and is expected to reach US$ 482.6 million by 2030 growing with a CAGR of 5.3% during the forecast period 2023-2030.

Autotransfusion is a process wherein a person receives their own blood for a transfusion instead of banked allogenic (separate-donor) blood. The goal of autotransfusion remains the same, to maintain a sterile field, prevent clotting of the collected blood, filtration of the blood, and administration to the patient.

Market Dynamics

An Increase in the Incidence of Vascular Surgeries is Driving the Autotransfusion System Market

The major factor that is driving the autotransfusion market is the increase in the number of vascular surgeries. A number of people are suffering from vascular diseases, which are leading to autotransfusion treatment in order to avoid rejection.

For instance, according to the Journal of Vascular Surgery, 107 operations were performed annually. Among the defined cohort of vascular surgeons, 11% performed more than 200 procedures, and 21% performed fewer than 50. On average, 107 vascular procedures were performed annually by a vascular surgeon. Thus, increase in the number of vascular surgeries is increasing the market growth.

The rise in Technological Advancements is Demanding the Global Autotransfusion System Market Growth

The introduction of new technologies and developments in autotransfusion has been the drive for the autotransfusion system market. For instance, in 2022, NIH revealed a study stating that a medical device intended to collect and wash intra-operatively collected blood to obtain a concentrated blood product at the end of the process.

The device integrates an innovative filtration technology through hollow fibers, allowing RBCs concentration but also platelets within the concentrated blood product and contaminant elimination.Thus technological developments havebeen a drive for the autotransfusion system market.

A lack of Skilled Professionals to Perform the Procedure can Hamper the Market Growth

Less number of skilled professionals to perform the autotransfusion system better will decline the growth of the market. As there is an increase in the number of different kinds of surgeries there is a need foran ample number of professionals to treat the patients. Thus reduced count of skilled professionals can decline the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a negative impact on the autotransfusion market. Many of the autotransfusion centers and diagnostic centers were closed, which has affected a large number of patients, and the transfusion rate has declined. The autotransfusion treatments have been postponed, which has created severe health issues This resulted in a significant increase in the number of patients lacking the treatment.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global autotransfusion system market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global autotransfusion system market growth over the forecast period.

Segment Analysis

The global autotransfusion system market is segmented based on product type, techniques, application, and end user.

The Cardiology Segment Holds the Dominant Position in the Market Over Forecast Period

Cardiology holds the most significant market share of around 41.7% during the forecast period. Autotransfusion of blood aspirated from the pericardium enables the operator to maintain hemodynamic stability (until surgery can be performed) and attempt to seal the cardiac perforation despite substantial and persistent fluid accumulation.

For instance, according to Lifespan Organization, there are about 500,000 open heart surgeries performed each year. It is most often used for complicated procedures, such as coronary artery bypass, or complex procedures to the aorta or the heart itself. An increase in surgeries required autotransfusion to be raised. Thus, the above factors are influencing the growth of the segment.

Geographical Analysis

Europe accounted for 27.9% of the Market Share Owing to the Prevalence of Surgeries and Increasing Technological Advancements

Due to the increased cardiac surgeries in this region ,there is an ample need for autotransfusion to be performed. The increase in the requirement for autotransfusion has increased the development of autotransfusion systems which has influenced the growth of the autotransfusion market in these regions.

For instance, according to CDS, 38 900 heart bypasses were conducted in Germany in 2020; this was more than double the number in any of the other EU Member States (16 400 were conducted in France). Hypertension is on the rise in Europe, especially in the rural and urban populations, which is increasing the incidence of cardiac surgeries.

Competitive Landscape

The major global players in the autotransfusion market include: BD, Fresenius Kabi, Zimmer, Armstrong Medical, Beijing ZKSK Technolgy, Haemonetics, LivaNova, Terumo BCT, Atrium Medical Corporation, Medtronic among others.

Why Purchase the Report?

  • To visualize the global autotransfusion system market segmentation based on product type, techniques, application, and end-user, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global autotransfusion system market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global autotransfusion system market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by End User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in incidence of surgeries with maximum blood loss
      • 4.1.1.2. Increase in the unavailability of the donors
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of an autotransfusion system
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements in product development
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Impact Analysis

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Intraoperative Autotransfusion Systems*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Postoperative Autotransfusion Systems
  • 8.4. Dual-Mode Autotransfusion Systems
  • 8.5. Autotransfusion Accessories

9. By Techniques

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Techniques
    • 9.1.2. Market Attractiveness Index, By Techniques
  • 9.2. Predeposit autologous donation (PAD) *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Acute normovolaemic haemodilution (ANH)
  • 9.4. Perioperative cell salvage (PCS)

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Orthopedic*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Neurology
  • 10.4. Cardiology
  • 10.5. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Specialty Clinics
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.7.1. U.S.
      • 12.2.7.2. Canada
      • 12.2.7.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.7.1. Germany
      • 12.3.7.2. U.K.
      • 12.3.7.3. France
      • 12.3.7.4. Spain
      • 12.3.7.5. Italy
      • 12.3.7.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.7.1. Brazil
      • 12.4.7.2. Argentina
      • 12.4.7.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.7.1. China
      • 12.5.7.2. India
      • 12.5.7.3. Japan
      • 12.5.7.4. Australia
      • 12.5.7.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Armstrong Medical.
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Beijing ZKSK Technology
  • 14.3. Medtronic
  • 14.4. Haemonetics
  • 14.5. LivaNova
  • 14.6. BD
  • 14.7. Zimmer
  • 14.8. Terumo BCT
  • 14.9. Atrium Medical Corporation
  • 14.10. Fresenius Kabi

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us